Literature DB >> 3163261

Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12).

C Turc-Carel1, A Aurias, F Mugneret, S Lizard, I Sidaner, C Volk, J P Thiery, S Olschwang, I Philip, M P Berger.   

Abstract

Since our initial reports on chromosomal studies in eight Ewing's sarcomas (ES), we have carried out similar investigations on 23 additional ES specimens following short-term culture of tumor cells (16 cases), and established in vitro cell lines (three cases) and on xenografted tumors in nude mice (four cases). We demonstrated the presence of the reciprocal t(11;22)(q24;q12) in every case except one that exhibited a complex t(11;22;14)(q24;q12;q11). On the basis of results from these additional 23 cases, we confirm the consistency of the t(11;22)(q24;q12) in ES. Moreover, we reviewed 54 ES cases reported by other investigators; when added to our 31 cases, this brings the total number to 85 unrelated cases of ES available for an evaluation of the frequency of involvement of bands 11q24 and 22q12 in translocations in ES. The standard t(11;22)(q24;q12) proved to be a remarkably consistent event, present in 83% of the cases. Five percent of the cases exhibited complex translocations involving a third chromosome in addition to chromosomes #11 and #22. In 4% of the cases variant translocations involved 22q12 but with a chromosome(s) other than #11. The breakpoint on chromosome 22q12 appears to be the most consistently observed event in 92% of the cases, whereas, the breakpoint at chromosome 11q24 was observed in 88% of the cases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163261     DOI: 10.1016/0165-4608(88)90285-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  88 in total

1.  Cytogenetic characterisation of small round cell tumours using fine needle aspiration.

Authors:  C Sreekantaiah; L Appaji; D Hazarika
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

Review 2.  Role of genetic and molecular profiling in sarcomas.

Authors:  Scott M Norberg; Sujana Movva
Journal:  Curr Treat Options Oncol       Date:  2015-05

3.  Ewing's Sarcoma of the Petrous Temporal Bone: Case Report and Literature Review.

Authors:  Aleem A Kadar; Matthew J Hearst; Margaret H Collins; Francesco T Mangano; Ravi N Samy
Journal:  Skull Base       Date:  2010-05

4.  Auto-stimulatory action of secreted caveolin-1 on the proliferation of Ewing's sarcoma cells.

Authors:  Aniruddha Sengupta; Silvia Mateo-Lozano; Oscar M Tirado; Vicente Notario
Journal:  Int J Oncol       Date:  2011-03-03       Impact factor: 5.650

Review 5.  Promiscuous partnerships in Ewing's sarcoma.

Authors:  Savita Sankar; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2011-07

6.  Additional chromosome 1q aberrations and der(16)t(1;16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors.

Authors:  B Stark; C Mor; M Jeison; R Gobuzov; I J Cohen; Y Goshen; J Stein; S Fisher; S Ash; I Yaniv; R Zaizov
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

7.  Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors.

Authors:  Barbara Patócs; Krisztina Németh; Miklós Garami; Gabriella Arató; Ilona Kovalszky; Miklós Szendrői; György Fekete
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

8.  Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.

Authors:  P Thorner; J Squire; S Chilton-MacNeil; P Marrano; J Bayani; D Malkin; M Greenberg; A Lorenzana; M Zielenska
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

9.  Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group.

Authors:  Steven G DuBois; Mark D Krailo; Stephen L Lessnick; Richard Smith; Zhengjia Chen; Neyssa Marina; Holcombe E Grier; Kimberly Stegmaier
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

Review 10.  Emerging chemotherapeutic strategies and the role of treatment stratification in Ewing sarcoma.

Authors:  Beatrice M Seddon; Jeremy S Whelan
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.